Literature DB >> 33730255

The Hepatitis C Continuum of Care Among HIV-Positive Persons with Heavy Alcohol Use in St. Petersburg, Russia.

Maria A Corcorran1,2, Natasha Ludwig-Baron3, Debbie M Cheng4, Dmitry Lioznov5,6, Natalia Gnatienko7, Gregory Patts8, Kaku So-Armah9, Elena Blokhina5, Sally Bendiks7, Evgeny Krupitsky5,10, Jeffrey H Samet9,11, Judith I Tsui12.   

Abstract

This study describes the self-reported prevalence of hepatitis C virus (HCV) coinfection and the HCV care continuum among persons enrolled in the St PETER HIV Study, a randomized controlled trial of medications for smoking and alcohol cessation in HIV-positive heavy drinkers and smokers in St. Petersburg, Russia. Baseline health questionnaire data were used to calculate proportions and 95% confidence intervals for self-reported steps along the HCV continuum of care. The cohort included 399 HIV-positive persons, of whom 387 [97.0% (95% CI 95.3-98.7%)] reported a prior HCV test and 315 [78.9% (95% CI 74.9-82.9%)] reported a prior diagnosis of HCV. Among those reporting a diagnosis of HCV, 43 [13.7% (95% CI 9.9-17.4%)] had received treatment for HCV, and 31 [9.8% (95% CI 6.6-13.1%)] had been cured. Despite frequent HCV testing in this HIV-positive Russian cohort, the proportion reporting prior effective HCV treatment was strikingly low. Increased efforts are needed to scale-up HCV treatment among HIV-positive Russians in St. Petersburg.

Entities:  

Keywords:  Continuum of care; HIV; Hepatitis C; Substance use

Mesh:

Year:  2021        PMID: 33730255      PMCID: PMC8222188          DOI: 10.1007/s10461-021-03214-y

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  46 in total

Review 1.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.

Authors:  Paul K Nelson; Bradley M Mathers; Benjamin Cowie; Holly Hagan; Don Des Jarlais; Danielle Horyniak; Louisa Degenhardt
Journal:  Lancet       Date:  2011-07-27       Impact factor: 79.321

2.  Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA.

Authors:  S Amele; L Peters; M Sluzhynska; A Yakovlev; A Scherrer; P Domingo; J Gerstoft; J P Viard; M Gisinger; R Flisiak; S Bhaghani; M Ristola; C Leen; E Jablonowska; G Wandeler; H Stellbrink; K Falconer; A D'Arminio Monforte; A Horban; J K Rockstroh; J D Lundgren; A Mocroft
Journal:  HIV Med       Date:  2019-02-08       Impact factor: 3.180

3.  Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine.

Authors:  Sarah Morey; Abi Hamoodi; Dee Jones; Tina Young; Craig Thompson; Julie Dhuny; Emma Buchanan; Carolyn Miller; Margaret Hewett; Manoj Valappil; Ewan Hunter; Stuart McPherson
Journal:  J Viral Hepat       Date:  2018-11-28       Impact factor: 3.728

4.  New data from the Addiction Severity Index. Reliability and validity in three centers.

Authors:  A T McLellan; L Luborsky; J Cacciola; J Griffith; F Evans; H L Barr; C P O'Brien
Journal:  J Nerv Ment Dis       Date:  1985-07       Impact factor: 2.254

5.  Alcohol use and hepatitis C virus treatment outcomes among patients receiving direct antiviral agents.

Authors:  Judith I Tsui; Emily C Williams; Pamela K Green; Kristin Berry; Feng Su; George N Ioannou
Journal:  Drug Alcohol Depend       Date:  2016-10-22       Impact factor: 4.492

6.  Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study.

Authors:  Tim Rhodes; Lucy Platt; Svetlana Maximova; Evgeniya Koshkina; Natalia Latishevskaya; Matthew Hickman; Adrian Renton; Natalia Bobrova; Tamara McDonald; John V Parry
Journal:  Addiction       Date:  2006-02       Impact factor: 6.526

Review 7.  Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis.

Authors:  Peter Vickerman; Matthew Hickman; Margaret May; Mirjam Kretzschmar; Lucas Wiessing
Journal:  Addiction       Date:  2009-11-16       Impact factor: 6.526

Review 8.  Access to hepatitis C treatment for people who inject drugs in low and middle income settings: Evidence from 5 countries in Eastern Europe and Asia.

Authors:  Niklas Luhmann; Julie Champagnat; Sergey Golovin; Ludmila Maistat; Edo Agustian; Ina Inaridze; Wai Moe Myint; Maia Butsashvili; Julie Bouscaillou
Journal:  Int J Drug Policy       Date:  2015-08-22

9.  Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe.

Authors:  H Stöver; F Meroueh; A Marco; K Keppler; P Saiz de la Hoya; R Littlewood; N Wright; F Nava; F Alam; S Walcher; L Somaini
Journal:  BMC Public Health       Date:  2019-01-08       Impact factor: 3.295

10.  Streamlining the screening cascade for active Hepatitis C in Russia: A cost-effectiveness analysis.

Authors:  Paul Jülicher; Vladimir P Chulanov; Nikolay N Pimenov; Ekaterina Chirkova; Anna Yankina; Claudio Galli
Journal:  PLoS One       Date:  2019-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.